Anaemia in children
171 results
101 - 171
Short‐acting erythropoiesis‐stimulating agents for anaemia in predialysis patients- Vitamin B12 supplementation during pregnancy for maternal and child health outcomes
- Fortification of salt with iron and iodine versus fortification of salt with iodine alone for improving iron and iodine status
- Interventions for treating iron deficiency anaemia in inflammatory bowel disease
- Preventive lipid‐based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes
- House modifications for preventing malaria
- Fortification of rice with vitamins and minerals for addressing micronutrient malnutrition
Lactose intolerance - Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome
- Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes: Cochrane systematic review
- Multiple micronutrient powders for home (point-of-use) fortification of foods in pregnant women: Cochrane systematic review
- The acutely ill infant (below 6 months)
- Education of family members to support weaning to solids and nutrition in later infancy in term‐born infants
- Drugs for treating urinary schistosomiasis: Cochrane systematic review
- Point-of-use fortification of foods with micronutrient powders containing iron in children of preschool and school-age: Cochrane systematic review
- Household interventions for secondary prevention of domestic lead exposure in children
- Psychological therapies for sickle cell disease and pain
- Sleep disorders in children and adolescents
- Interventions for chronic kidney disease in people with sickle cell disease
- Iron-chelating agents for treating malaria: Cochrane systematic review
- Growth hormone therapy for people with thalassaemia
- Hydroxyurea (hydroxycarbamide) for sickle cell disease
- Stomatitis in children
- Dipyrone for acute primary headaches: Cochrane systematic review
- Interventions for preventing silent cerebral infarcts in people with sickle cell disease
- Mononucleosis
- Infant gastric reflux
- Antihelminthics in helminth‐endemic areas: effects on HIV disease progression
- Parenteral versus oral iron therapy for adults and children with chronic kidney disease
- Thrombocytopenia
- Folate supplementation in people with sickle cell disease
- Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews
- Ataxia
- Intermittent preventive treatment for malaria in infants
- Vaccines for preventing invasive salmonella infections in people with sickle cell disease
- Fortification of wheat and maize flour with folic acid for population health outcomes
- Fortification of staple foods with zinc for improving zinc status and other health outcomes in the general population
- ADHD
- Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease
- Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in low and middle income countries
- Transfusion of red blood cells stored for shorter versus longer duration for all conditions: Cochrane systematic review
- Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support
- Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax
- Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer
- Infections in immunosuppressed and cancer patients
- Bacterial diseases in warm climates
- Vaccinations
- Transfusion thresholds for guiding red blood cell transfusion
- Supplementation with multiple micronutrients for breastfeeding women for improving outcomes for the mother and baby
- Mefloquine for preventing malaria in pregnant women
- Phytomedicines (medicines derived from plants) for sickle cell disease
- Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
- Intravenous iron therapy for non‐anaemic, iron‐deficient adults
- Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders: Cochrane systematic review
- The premature infant in outpatient care
- Serum or plasma ferritin concentration as an index of iron deficiency and overload
- Vitamin E supplementation in people with cystic fibrosis
- Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia
- Porphyrias
- Benign gynaecological lesions and tumours
- Azathioprine and 6‐mercaptopurine for maintenance of surgically‐induced remission in Crohn's disease
- Early erythropoiesis‐stimulating agents in preterm or low birth weight infants
- Treatment for HIV‐associated cryptococcal meningitis
- Hereditary coagulation factor deficiencies